Location History:
- Shiga, JP (1995)
- Shiga-ken, JP (1998)
Company Filing History:
2 out of 16 
2 out of 232 Years Active: 1995-1998
Title: Innovations by Masahiro Nakatani
Introduction
Masahiro Nakatani is a notable inventor based in Shiga, Japan. He has made significant contributions to the field of medical technology, particularly in the area of blood treatment and cancer prognosis assessment. With a total of two patents to his name, Nakatani's work reflects a commitment to improving patient care through innovative solutions.
Latest Patents
Nakatani's latest patents include a granulocyte removing apparatus and a method for assessing the prognosis of a patient undergoing therapy for cancer. The granulocyte removing apparatus is designed to remove granulocytes from blood by utilizing a carrier that has a higher affinity for granulocytes than for lymphocytes. This apparatus features a granulocyte-adsorbing portion that encloses the carrier, along with a blood inflow port and a blood outflow port to facilitate the flow of blood through the system. The method for assessing cancer prognosis involves measuring the granulocyte/lymphocyte ratio in a patient's blood and comparing it to a normal range. An improved prognosis is indicated when the G/L value falls within this range.
Career Highlights
Throughout his career, Nakatani has worked with several prominent companies, including Japan Immunoresearch Laboratories Co., Ltd. and Sekisui Kagaku Kogyo Kabushiki Kaisha. His experience in these organizations has allowed him to develop and refine his innovative ideas, contributing to advancements in medical technology.
Collaborations
Nakatani has collaborated with notable individuals in his field, including Masakazu Adachi and Seiichirou Honda. These partnerships have likely enhanced his research and development efforts, leading to the successful creation of his patents.
Conclusion
Masahiro Nakatani's contributions to medical technology through his patents demonstrate his dedication to improving healthcare outcomes. His innovative approaches to blood treatment and cancer prognosis assessment highlight the importance of research and development in the medical field.